CD86 and neoplasm: SLT also plays a crucial role in modulating the tumor immune microenvironment by influencing macrophage polarization: it promotes the shift of M0 macrophages toward the M1 phenotype, marked by increased CD86+ cells, while inhibiting the M2 phenotype, characterized by decreased CD206+ cells.